- AU$13.27m
- AU$11.98m
- AU$0.51m
Annual income statement for Renerve, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.128 | 0.177 | 0.272 | 0.51 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.177 | 0.245 | 0.271 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.78 | 1.98 | 3.16 | 4.01 | 6.08 |
| Operating Profit | -1.78 | -1.86 | -2.98 | -3.73 | -5.57 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.76 | -1.8 | -2.98 | -3.73 | -5.57 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.76 | -1.8 | -2.98 | -3.73 | -5.57 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.76 | -1.8 | -2.98 | -3.73 | -5.57 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.76 | -1.8 | -2.98 | -3.73 | -5.57 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.012 | -0.013 | -0.021 | -0.026 | -0.035 |